----
Current ValuationThe current P/E ratio is 45.63, within the reasonable range, cheaper than 27.17% of the time in the past 5 years, and the industry ranks 94/222, the industry Median 22.63.
45.63xP/E
¥17.42Stock price
¥0.38Earnings per share
45.63xP/E
Stock price¥17.42Earnings per share¥0.38
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 32.69x
- Typical range
- 24.09x–54.03x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 22.63x
016324864
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 22.63x
0x40x80x120x160x200x
| Name/Symbol | |||
|---|---|---|---|
002653SZHaisco | 51.08x | 597.96% | ¥66.58B |
002821SZAsymchem | 45.91x | 16.47% | ¥54.38B |
300765SZCSPC Innovation | 48.98x | 628.47% | ¥48.63B |
002294SZSalubris | 48.30x | 29.31% | ¥34.54B |
300199SZHYBIO | 51.76x | -- | ¥20.80B |
301569SZNOVAST | 53.95x | -- | ¥16.79B |
603858SHBUCHANG PHARMA | 56.05x | -- | ¥15.80B |
300725SZPHARMABLOCK | 48.84x | 18.18% | ¥10.82B |
002626SZKingdomway | 45.63x | 26.67% | ¥10.63B |
600851SHHX GROUP | 55.18x | -- | ¥10.54B |
600789SHLKPC | 54.37x | -- | ¥7.41B |
688553SHHUIYU PHARMACEUTICAL | 55.34x | -- | ¥7.15B |
002390SZxinbang phar. | 42.56x | -- | ¥5.89B |
301393SZHighfine | 47.00x | -- | ¥5.80B |
002907SZPharscin Pharma | 58.30x | -- | ¥5.47B |
002940SZALK | 48.07x | -- | ¥5.31B |
300584SZHicin Pharmaceutical | 53.02x | -- | ¥3.80B |
002923SZRundu Pharma | 53.93x | -- | ¥3.06B |
002864SZPanlong Pharmaceutical | 48.18x | -- | ¥3.04B |
301331SZENWEI PHARMACEUTICAL | 59.56x | -- | ¥2.25B |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
